Research
Clinical Trials
PARP Inhibitors Show Promise in Ovarian Cancer Treatment
Written by Marilyn Huang, M.D. Gynecologic oncologist Sylvester Comprehensive Cancer Institute About 23,000 cases of biologically epithelial ovarian cancer (EOC), which includes fallopian tube and primary peritoneal carcinoma, are diagnosed annually, They…
COVID-19
Coronavirus Treatments: Here's Where We Are Today
While much of the world focuses on a vaccine for COVID-19, scientists are also busy studying and developing potential treatments. The two-pronged approach has led to a better understanding of…
Cancer
Ovarian Cancer - Or Is It?
Written by Matthew Schlumbrecht, M.D., M.P.H. and Sophia George, Ph.D. Gynecologic Oncology Sylvester Comprehensive Cancer Center In 2020, there will be an estimated 22,000 new cases of ovarian cancer…